A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
Advances in DNA sequencing technology help forensic biologists identify suspects where traditional DNA profiling has failed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results